Zou, Xinyang
Chen, Lina
Shi, Yisen
Yang, Kaitai
Chen, Xinyan
Zeng, Aiying
Peng, Xiaolei
Chen, Ke
Chen, Xuanjie
Yang, Zeqiang
Lin, Xuan
Su, Jiaqi
Wan, Lijun
Wu, Shenglong
Wang, Weiru
Zhong, Qihong
Zheng, Jiayi
Lin, Fabin
Ye, Qinyong
Cai, Guoen
,
Wang, Huaicheng
Wang, Xuefei
Fu, Shibo
Lin, Yixiang
Ke, Peiyong
Hong, Yi
Li, Yifei
Xue, Yangye
Lin, Tianxin
Hu, Guoping
Lin, XuJingxiong
Huang, Tingting
Lu, Xiaoyang
Zhuang, Weijiang
He, Jiarui
Funding for this research was provided by:
National Natural Science Foundation of China (U23A20423)
National Natural Science Foundation of China (82271270)
Fujian Province Joint Funds for the Innovation of Science and Technology (2019Y9070)
Article History
Received: 22 September 2025
Accepted: 3 February 2026
First Online: 13 February 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Fujian Medical University Union Hospital Ethics Committee (approval number: 2022KY075). The trial was registered with the China Clinical Trial Registry ( ) on 28 February 2022 prior to initiation (ChiCTR2200057109). Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.